BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 17458439)

  • 1. Hereditary angioedema presenting in late middle age after angiotensin-converting enzyme inhibitor treatment.
    Ricketti AJ; Cleri DJ; Ramos-Bonner LS; Vernaleo JR
    Ann Allergy Asthma Immunol; 2007 Apr; 98(4):397-401. PubMed ID: 17458439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unmasking of acquired autoimmune C1-inhibitor deficiency by an angiotensin-converting enzyme inhibitor.
    Kleiner GI; Giclas P; Stadtmauer G; Cunningham-Rundles C
    Ann Allergy Asthma Immunol; 2001 Apr; 86(4):461-4. PubMed ID: 11345293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First case of homozygous C1 inhibitor deficiency.
    Blanch A; Roche O; Urrutia I; Gamboa P; Fontán G; López-Trascasa M
    J Allergy Clin Immunol; 2006 Dec; 118(6):1330-5. PubMed ID: 17137866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does angiotensin-converting enzyme inhibitor use exacerbate hereditary angioedema?
    Hassen GW; Tu TJ; Wei DH; Hwang A; Lamothe R; Costea A; Liu LL; Smith T; Mualim F; Johnston P; Ng JM; Usmani S; Kalantari H
    J Emerg Med; 2013 Oct; 45(4):602-8. PubMed ID: 23890533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paternal mosaicism and hereditary angioedema in a Taiwanese family.
    Yu TC; Shyur SD; Huang LH; Wen DC; Li JS
    Ann Allergy Asthma Immunol; 2007 Oct; 99(4):375-9. PubMed ID: 17941288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C1-inhibitor (C1-INH) autoantibodies in hereditary angioedema. Strong correlation with the severity of disease in C1-INH concentrate naïve patients.
    Varga L; Széplaki G; Visy B; Füst G; Harmat G; Miklós K; Németh J; Cervenak L; Karádi I; Farkas H
    Mol Immunol; 2007 Feb; 44(6):1454-60. PubMed ID: 16750855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Acquired C1 esterase inhibitor deficiency via bradykinin-mediated angioedema: Four cases].
    Jacquin-Porretaz C; Castelain F; Daguindau E; Seilles E; Nardin C; Aubin F; Pelletier F
    Ann Dermatol Venereol; 2018 Oct; 145(10):598-602. PubMed ID: 29673745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angioedema from angiotensin-converting enzyme (ACE) inhibitor treated with complement 1 (C1) inhibitor concentrate.
    Nielsen EW; Gramstad S
    Acta Anaesthesiol Scand; 2006 Jan; 50(1):120-2. PubMed ID: 16451161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional C1-inhibitor diagnostics in hereditary angioedema: assay evaluation and recommendations.
    Wagenaar-Bos IG; Drouet C; Aygören-Pursun E; Bork K; Bucher C; Bygum A; Farkas H; Fust G; Gregorek H; Hack CE; Hickey A; Joller-Jemelka HI; Kapusta M; Kreuz W; Longhurst H; Lopez-Trascasa M; Madalinski K; Naskalski J; Nieuwenhuys E; Ponard D; Truedsson L; Varga L; Nielsen EW; Wagner E; Zingale L; Cicardi M; van Ham SM
    J Immunol Methods; 2008 Sep; 338(1-2):14-20. PubMed ID: 18655790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angioedema due to acquired C1-inhibitor deficiency: a bridging condition between autoimmunity and lymphoproliferation.
    Cugno M; Castelli R; Cicardi M
    Autoimmun Rev; 2008 Dec; 8(2):156-9. PubMed ID: 19014872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of increased prevalence of immunoregulatory disorders in hereditary angioedema due to C1-inhibitor deficiency.
    Farkas H; Csuka D; Gács J; Czaller I; Zotter Z; Füst G; Varga L; Gergely P
    Clin Immunol; 2011 Oct; 141(1):58-66. PubMed ID: 21636327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent Angioedema: Occurrence, Features, and Concomitant Diseases in an Italian Single-Center Study.
    Triggianese P; Guarino MD; Pellicano C; Borzi M; Greco E; Modica S; De Carolis C; Perricone R
    Int Arch Allergy Immunol; 2017; 172(1):55-63. PubMed ID: 28222436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of angioedema associated with the use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
    Malde B; Regalado J; Greenberger PA
    Ann Allergy Asthma Immunol; 2007 Jan; 98(1):57-63. PubMed ID: 17225721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis and treatment of hereditary angioedema.
    Canonica GW; Rossi O
    Panminerva Med; 2012 Sep; 54(3):241-53. PubMed ID: 22801442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presentation, diagnosis and treatment of angioedema without wheals: a retrospective analysis of a cohort of 1058 patients.
    Mansi M; Zanichelli A; Coerezza A; Suffritti C; Wu MA; Vacchini R; Stieber C; Cichon S; Cicardi M
    J Intern Med; 2015 May; 277(5):585-93. PubMed ID: 25196353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic test indications and interpretations in patients with hereditary angioedema.
    Weiler CR; van Dellen RG
    Mayo Clin Proc; 2006 Jul; 81(7):958-72. PubMed ID: 16835976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hereditary angioedema first apparent in the ninth decade during treatment with ACE inhibitor.
    Berkun Y; Shalit M
    Ann Allergy Asthma Immunol; 2001 Aug; 87(2):138-9. PubMed ID: 11527246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Idiopathic Nonhistaminergic Acquired Angioedema Versus Hereditary Angioedema.
    Andrási N; Veszeli N; Kőhalmi KV; Csuka D; Temesszentandrási G; Varga L; Farkas H
    J Allergy Clin Immunol Pract; 2018; 6(4):1205-1208. PubMed ID: 29715562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hereditary angioedema: therapeutic effect of danazol on C4 and C1 esterase inhibitors.
    Fabiani JE; Paulin P; Simkin G; Leoni J; Palombarani S; Squiquera L
    Ann Allergy; 1990 Apr; 64(4):388-92. PubMed ID: 2108593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis and treatment of bradykinin-mediated angioedema: outcomes from an angioedema expert consensus meeting.
    Craig TJ; Bernstein JA; Farkas H; Bouillet L; Boccon-Gibod I
    Int Arch Allergy Immunol; 2014; 165(2):119-27. PubMed ID: 25401373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.